ADJUVANT NITROSOUREA THERAPY FOR GLIOBLASTOMA

[1] BAND PR, 1974, P AM ASSOC CANC RES, V15, P161

[2] BARKER M, 1973, CANCER RES, V33, P976

[3] GLIOBLASTOMA MULTIFORME - CONTROLLED TRIAL TO ASSESS VALUE OF SPECIFIC ACTIVE IMMUNOTHERAPY IN PATIENTS TREATED BY RADICAL SURGERY AND RADIOTHERAPY [J]. BRITISH JOURNAL OF CANCER, 1973, 27 (03) : 253 - 267

[4] Brisman R, 1968, N Engl J Med, V279, P1289

[5] ELVIDGE AR, 1935, P ASSOC NERV MENT DI, V16, P107

[6] FEWER D, 1972, CANCER CHEMOTH REP 1, V56, P421

[7] IRIARTE PV, 1966, CANCER, V19, P1187, DOI 10.1002/1097-0142(196609)19:9<1187::AID-CNCR2820190902>3.0.CO

[8] 2-T

[9] GLIOBLASTOMA MULTIFORME - ITS TREATMENT AND SOME FACTORS EFFECTING SURVIVAL [J]. ARCHIVES OF NEUROLOGY, 1969, 20 (02) : 161 - &

[10] MAYO JG, 1972, CANCER CHEMOTH REP 1, V56, P183

[1] BAND PR, 1974, P AM ASSOC CANC RES, V15, P161

[2] BARKER M, 1973, CANCER RES, V33, P976

[3] GLIOBLASTOMA MULTIFORME - CONTROLLED TRIAL TO ASSESS VALUE OF SPECIFIC ACTIVE IMMUNOTHERAPY IN PATIENTS TREATED BY RADICAL SURGERY AND RADIOTHERAPY [J]. BRITISH JOURNAL OF CANCER, 1973, 27 (03) : 253 - 267

[4] Brisman R, 1968, N Engl J Med, V279, P1289

[5] ELVIDGE AR, 1935, P ASSOC NERV MENT DI, V16, P107

[6] FEWER D, 1972, CANCER CHEMOTH REP 1, V56, P421

[7] IRIARTE PV, 1966, CANCER, V19, P1187, DOI 10.1002/1097-0142(196609)19:9<1187::AID-CNCR2820190902>3.0.CO

[8] 2-T

[9] GLIOBLASTOMA MULTIFORME - ITS TREATMENT AND SOME FACTORS EFFECTING SURVIVAL [J]. ARCHIVES OF NEUROLOGY, 1969, 20 (02) : 161 - &

[10] MAYO JG, 1972, CANCER CHEMOTH REP 1, V56, P183